Search clinical trials for: AMG 706

Total 1930 results

Gedeon Richter Plc.

Recruiting

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Spain, Czechia, Italy, France
Amgen

Completed

Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Amgen

Completed

Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer
UCB Pharma

Completed

Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Epilepsy

United States, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Norway, Poland, Russian Federation, Serbia, Singapore, South Africa, Spain, Sweden, Swit... and more
PharmaMar

Completed

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma (ADMYRE)

Relapsed/Refractory Multiple Myeloma

United States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
Durata Therapeutics Inc., an affiliate of Allergan...

Completed

Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Abscess | Cellulitis | Surgical Site Infection | Wound Infection

United States, Bulgaria, Croatia, Estonia, Georgia, Hungary, Latvia, Romania, Russian Federation, Serbia, South Africa, Ukraine
UCB Pharma

Completed

Transdermal Rotigotine User Surveillance Study (TRUST)

Idiopathic Parkinson Disease

Czechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
UCB BIOSCIENCES GmbH

Completed

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

Arthritis, Psoriatic

Germany, United States, Argentina, Belgium, Brazil, Canada, Czechia, France, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB BIOSCIENCES GmbH

Completed

Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

Spondyloarthropathies

Germany, United States, Argentina, Belgium, Brazil, Canada, Czechia, France, Hungary, Italy, Mexico, Poland, Spain, United Kingdom, Netherlands
UCB Pharma

Completed

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Partial Epilepsies

United States, Austria, Bulgaria, Czechia, Denmark, Finland, France, Greece, Italy, Mexico, Romania, Russian Federation, Spain, Switzerland, Turkey
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With Hypercholesterolemia

Disease | Dyslipidemias | Hypercholesterolemia
University Hospital, Grenoble

Unknown

Arterial Properties of Thoracic Aorta Disease (ao_diss)

Blood Pressure

France
Amgen

Terminated

A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

Advanced Non-squamous NSCLC
Amgen

Completed

Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors

Solid Tumors
Amgen

Terminated

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Pancreatic Cancer | Esophageal Cancer | Lung Cancer
Amgen

Terminated

An Open Label Treatment Extension Study of AMG 706

Solid Tumors
Amgen

Terminated

A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Breast Cancer | Breast Neoplasms | Breast Tumors | Locally Recurrent and Metastatic Breast Cancer
Amgen

Completed

Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors

Tumors
University of Southampton
East Kent Hospitals University NHS Foundation Trust

Unknown

Family Factors in Young People With Diabetes: a Qualitative Study

Type 1 Diabetes

United Kingdom
Selcuk University

Completed

The Effect of Breastfeeding Education Given to Family Members on Breastfeeding Parameters

Breastfeeding

Turkey
AbbVie (prior sponsor, Abbott)

Completed

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

Crohn's Disease

Japan
Amgen
Takeda

Completed

Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

Advanced Gastrointestinal Stromal Tumor
AbbVie

Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Israel, Japan, Australia, Spain, Germany
Amgen

Completed

A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

Histologically or Cytologically Documented Solid Tumors
Amgen

Completed

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Thyroid Cancer
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome

United States
Amgen

Completed

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

Gastrointestinal Cancer
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Lymphoma | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Lymphoproliferative Disorder

United States
Institut National de la Santé Et de la Recherche...
French private agencies

Completed

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Healthy

France
Abbott Medical Devices

Completed

ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"

Carotid Atherosclerosis | Carotid Artery Disease
Chinese PLA General Hospital

Not yet recruiting

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Papillary Thyroid Cancer
Encore Medical, L.P.
DJO Incorporated

Terminated

Post Market Study of the 3DKnee™ With E-plus Insert (e-plus)

Osteoarthritis | Traumatic Arthritis | Degenerative Joint Disease

United States
Zeliha Aytekin

Completed

Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic

COVID-19 | Anxiety | Fear

Turkey
Baylor Research Institute
Shire

Unknown

A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children

Quality of Life | Renal Insufficiency | Cardiac Event

United States
Amgen

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Advanced Solid Tumors
Takeda

Terminated

Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Rigshospitalet, Denmark
King's College London; Deakin University

Active, not recruiting

The Development and Validation of EMPOWER-UP: a Generic Questionnaire for Measuring Empowerment in Patient-provider Relationships

Diabetes | Cancer | Mental Disorder

Australia, Denmark, United Kingdom
Smith & Nephew, Inc.

Terminated

Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy (MILE)

Torn Meniscus

United States
Amgen

Completed

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Locally Recurrent and Metastatic Breast Cancer
Amgen
Takeda

Terminated

MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Non-Small Cell Lung Cancer
Ain Shams University

Recruiting

Intrathecal Prilocaine and Adductor Canal Block vs Intrathecal Bupivacaine Alone for Ambulatory Knee Arthroscopy

Post Operative Pain

Egypt
Superior University

Active, not recruiting

Development of Stance Control Orthotic Knee Joint For Improvement of KAFO Users

Knee | Ankle Osteoarthritis

Pakistan
Seoul National University Bundang Hospital

Recruiting

CLIC1 in Patients Presenting PD

Hip Fractures | Hip Disease

Korea, Republic of
Holland Bloorview Kids Rehabilitation Hospital
Ontario Neurotrauma Foundation

Completed

The LETS Study: A Longitudinal Evaluation of Transition Services (LETS)

Cerebral Palsy | Brain Injuries | Spinal Dysraphism

Canada
Seoul National University Bundang Hospital

Completed

Remimazolam and Remifentanil Without Neuromuscular Blocking Agent

Myoma;Uterus | Polyp Endometrium | Unspecified Condition Associated With Female Genital Organs and Menstrual Cycle

Korea, Republic of
Ipsen

Completed

Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm

Blepharospasm

United States
Amgen

Completed

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Lung Cancer
Oslo Metropolitan University
University of Oslo; Olympic Seafood AS

Completed

Health Beneficial Effects of Krill Oil and Lean and Fatty Fish

Healthy
Sidney Kimmel Cancer Center at Thomas Jefferson...
Amgen; Susan G. Komen Breast Cancer Foundation

Withdrawn

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer

United States

Search clinical trials for: AMG 706

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations